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In this paper, by using self-association defective RAD51 mutants, we show that the
phosphorylation of RAD51 by c-ABL stabilizes RAD51 chromatin association. This activation is
abolished by replacement of Tyr-315 with Phe, indicating that the phosphorylation of Tyr-315 is the
origin of this activation. However, c-ABL cannot restore the defect of the self-association defective
mutants in IR-induced nuclear focus formation, suggesting that c-ABL functions during the early
phase of RAD51 chromatin assembly, before RAD51 nucleo-protein filament formation. Our findings
thus suggest a new model for the regulation of early steps of homologous recombination repair.
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The assembly of RAD51 recombinase on DNA substrates at sites of breakage is essential
for their repair by homologous recombination repair (HRR). The signaling pathway that
triggers RAD51 assembly at damage sites to form subnuclear foci is unclear. Here, we
provide evidence that c-ABL, a tyrosine kinase activated by DNA damage which
phosphorylates RAD51 on Tyr-315, works at a previously unrecognized, proximal step to
initiate RAD51 assembly. We first show that c-ABL associates with chromatin after DNA
damage in a manner dependent on its kinase activity. Using RAD51 mutants that are unable to
oligomerize to form a nucleoprotein filament, we separate RAD51 assembly on DNA to form
foci into two steps: stable chromatin association followed by oligomerization. We show that
phosphorylation on Tyr-315 by c-ABL is required for chromatin association of
oligomerization-defective RAD51 mutants, but is insufficient to restore oligomerization. Our
findings suggest a new model for the regulation of early steps of HRR.
Keywords: homologous recombination repair, RAD51, BRCA2, ATM, c-ABL, tyrosine
phosphorylation.
3Introduction
HRR is a major pathway for the resolution of DNA double-strand breaks (DSBs) in the somatic
cells of higher eukaryotes, and is mediated by RAD51, the eukaryal orthologue of bacterial RecA. A
key step in HRR involves the assembly of RAD51 onto DNA substrates at the site of DNA breakage to
form an ordered, helical nucleoprotein filament, which catalyzes homologous pairing and the strand
exchange reaction [1]. This RAD51 assembly is marked in cells by the formation of nuclear foci
containing RAD51 in vertebrate cells of avian, rodent or human origin. Genetic studies in these
organisms demonstrate that a number of ancillary molecules are necessary for RAD51 focus formation
after DNA damage. These include the breast cancer suppressor, BRCA2, as well as the RAD51
paralogues XRCC2, XRCC3 and RAD51B-D.  Available evidence suggests that these ancillary
molecules assist RAD51 focus formation either by working as ‘recombination mediators’, which
displace proteins like replication protein A from DNA to enable RAD51 nucleation, or by directly
promoting RAD51 loading [2, 3]. An important unresolved question concerns the nature of the
signaling process that triggers RAD51 assembly at sites of DNA breakage.
A c-ABL, ubiquitously expressed non-receptor-type tyrosine kinase, is activated by
ionizing radiation (IR) in an ATM-dependent manner [4, 5] and plays important roles in
growth arrest and cell death [6]. The results of previous studies indicate that c-ABL is
involved in HRR through the phosphorylation of RAD51. c-ABL was shown to inhibit
binding of RAD51 to DNA in vitro by phosphorylating it on Tyr-54 in one study [7]; the
other study showed that c-ABL phosphorylates RAD51 on Tyr-315 and this phosphorylation
enhances the association of RAD51 with RAD52, one of recombination mediator proteins [8].
In addition, the oncogenic form of c-ABL fusion kinase (BCR/ABL) has been shown to
enhance RAD51 expression and to phosphorylate it on Tyr-315, resulting in resistance to
drugs such as cisplatin and mitomycin C [9]. On the other hand, we have shown that arg-/-
(ARG is the only other known member of the c-ABL family) and atm-/- DT40 chicken B cells
show a mild impairment in RAD51 focus formation and HRR capacity [10-12]. More recently,
a reduction in IR-induced RAD51 focus formation has also been observed in atm-/- and abl-/-
mouse embryonic fibroblasts and ATM-deficient human cells [13]. These findings imply that,
in higher vertebrates, c-ABL family plays some regulatory roles in RAD51 functions in an
ATM-dependent manner, though they are not apparently essential components of the HRR
machinery. However, how these ABL tyrosine kinase members mechanistically regulate in
vivo RAD51 functions remains to be established.
4In the present study, we show that c-ABL is recruited and activated in the chromatin in its
kinase activity dependent manners. By using self-association defective RAD51 mutants, we
further show that the phosphorylation of RAD51 by c-ABL stabilizes RAD51 chromatin
association. This activation is abolished by replacement of Tyr-315 with Phe, indicating that
the phosphorylation of Tyr-315 is the origin of this activation. However, c-ABL cannot restore
the defect of the self-association defective mutants in IR-induced nuclear focus formation,
suggesting that c-ABL functions during the early phase of RAD51 chromatin assembly,
before RAD51 nucleo-protein filament formation.
MATERIALS AND METHODS
Expression plasmids. Tyr-54 and Tyr-315 of human RAD51 were mutated to Phe and Arg-
167 of human RAD51 was mutated to Gly, using a PCR strategy. These RAD51 mutant
cDNAs were then inserted into pEF-BOS expression vector containing HA-tag. (HA-RAD51-
Y54F, HA-RAD51-Y315F and HA-RAD51-R167G). RAD51wt and R167G cDNAs were
also inserted into the pFLAG-CMV-2 expression vector (Sigma) (Flag-RAD51-wt and Flag-
RAD51-R167G). Using HA-RAD51-R167G as a template, we constructed HA-RAD51-
R167G/Y54F and HA-RAD51-R167G/Y315F expression plasmids by PCR strategy.
Cell culture, transfection, and subcellular fractionation. 293T human embryonic kidney
cells were cultured in DMEM supplemented with 10% FBS and antibiotics, in a 5% CO2
incubator at 37ºC. Transient transfection were performed by using FuGENE 6 Transfection
Reagent (Roche). Subcellular fractionation was carried out essentially as described [14].
Antibodies. Antibodies recognizing specifically the phosphorylated human RAD51 (either
at Tyr-54 or Tyr-315) were generated by immunization of rabbit with the ovalbumin (OVA)-
conjugated peptides (NeoMPS, France): the phosphopeptide
TVEAVAY(PO3H2)APKKELINIKGIC was used to generate the antibody recognizing
RAD51 phosphorylated at Tyr-54 and the phosphopeptide KIY(PO3H2)DSPCLPEAEAMFY
for antibody recognizing RAD51 phosphorylated at Tyr-315. The antibodies were purified by
using affinity chromatography with on Sulfolink gels [9] conjugated with the corresponding
phosphorylated and unphosphorylated peptides, as described by the manufacture. Rabbit anti-
human RAD51 antibody (a gift of Dr. Akira Shinohara) was used for RAD51 focus detection
5and immunoblot analysis as a primary antibody. Other primary antibodies for immunoblot
analysis were: mouse monoclonal antibodies; anti-Flag M5, anti-β-actin AC15, anti-α-
tubulin B-5-1-22 ( these were purchased from Sigma. ), anti-human BRCA2 Ab-1
(CALBIOCHEM), anti-Histone H3 6-6-2 (Upstate); rabbit anti-GFP antibody (abcam).
Secondary antibodies for immunoblot analysis were: goat anti-rabbit IgG horseradish
peroxidase conjugated (CHEMICON) and peroxidase labeled goat anti-mouse IgG
(FUNAKOSHI). Protein G Sepharose beads (GE Healthcare) was used in
immunoprecipitation.
Results and Discussion
The RAD51 protein is known to form helical filament structures, which is considered to be
the active form for homologous pairing and strand exchange. Structural based mutagenesis
revealed that the Phe-86 residue is directly involved in the monomer-monomer interaction of
the human RAD51 filament [15, 16]. The human RAD51 filament model constructed with the
reported crystal structure of the archaeal RadA RAD51 filament [17] suggests that the Arg-
167 residue is also located in the monomer-monomer interface of the active filament of
RAD51 (Supplementary Fig. 1). We therefore replaced Arg-167 of human RAD51 by Gly,
which does not have side chain moiety, and studied whether this mutation (R167G) influences
monomer-monomer interactions involved in RAD51 self-association, like the substitution of
Phe-86 with Glu (F86E) does. Flag-tagged wild-type (WT) or R167G mutant RAD51 proteins
were, thus, transiently expressed in 293T cells, and examined for their ability to bind
endogenous RAD51 and BRCA2 with or without IR stimulation, by using co-
immunoprecipitation method. We found that RAD51-WT and RAD51-R167G proteins
displayed comparable abilities to bind endogenous BRCA2. However, while the RAD51-WT
protein showed the IR-inducible ability to bind endogenous RAD51, RAD51-R167G
completely lost the ability to interact with endogenous RAD51 (Supplementary Fig. 2A). The
inability of RAD51-R167G to interact with other RAD51 molecules in vivo was also
confirmed by the results of co-immunoprecipitation experiments with co-expressed HA-
tagged RAD51-R167G and Flag-tagged RAD51-WT (data not shown).
To establish the validity of the results of experiments with the RAD51-R167G mutant, we
6analyzed the ability of GFP-tagged RAD51-F86E or RAD51-SA208-209ED (Ser-208 and
Ala-209 were replaced with Glu and Asp, respectively) mutants to interact with endogenous
RAD51 or BRCA2. In agreement with the results of the previous studies [15, 16], GFP-
RAD51-SA208-209ED retained the ability to bind endogenous RAD51, but was unable to
bind endogenous BRCA2. On the other hand, GFP-RAD51-F86E retained the ability to bind
endogenous BRCA2, but showed the reduced ability to interact with endogenous RAD51
(Supplementary Fig. 2B).
Our previous in vitro studies showed that mutant RAD51 proteins, in which Tyr-315 is
replaced with Asp or Glu to mimic phosphorylation, were proficient in double-strand DNA
(dsDNA) binding, but were defective in dsDNA unwinding, probably due to defect in
filament formation on dsDNA [18]. Consistent with these findings, fluorescence spectroscopic
analysis of the RAD51-Y315W mutant suggested that Tyr-315 is closed to the subunit-subunit
interacting site [19] (see also Supplementary Fig1). Thus, it is of interest to study whether c-
ABL has any effects on in vivo behaviors of self-association-defective RAD51 mutants. Since
RAD51filament formation in vivo is a complex cellular process, especially in higher
vertebrate cells, requiring transport to and assembly in chromatin, before RAD51
nucleoprotein filament formation on damaged DNA [14, 20], we examined effects of c-ABL
on nuclear transport or chromatin association of RAD51. HA-tagged RAD51-WT or RAD51-
R167G was transiently co-expressed with Flag-tagged active (wt) or kinase-dead (kd) c-ABL
in 293T cells, and cells were fractionated into cytoplasmic, nuclear and chromatin-associated
fractions. Anti-human RAD51 antibodies were used to detect endogenous RAD51 as well as
transiently expressed HA-tagged RAD51, and a-tubulin and Histone H3 were used as specific
makers for the soluble cytoplasmic and insoluble chromatin-associated fractions, respectively.
As overall distributions of RAD51-WT, RAD51-R167G, endogenous RAD51 and c-ABL
were comparable in the cytoplasmic and nuclear fractions (data not shown), data for protein
levels in the nuclear fraction was not shown for simplicity.
Fig. 1A reveals several interesting findings. Firstly, while we found extensive chromatin
association of c-ABL-wt (first row, lanes 8 and 11), the chromatin association of c-ABL-kd
was minimal (first row, lanes 9 and 12), indicating that the efficient chromatin association of
c-ABL requires intact tyrosine kinase activity. This was further confirmed by the results of
experiment with imatinib, a specific inhibitor of c-ABL [21], that imatinib effectively inhibits
7c-ABL chromatin association (Supplementary Fig. 3). Interestingly, the electrophoretic
mobility of c-ABL-wt in the chromatin fraction (lanes 8 and 11) was significantly retarded as
compared with those of c-ABL-kd in the chromatin fraction (lanes 9 and 12) or c-ABL-wt in
the soluble cytoplasmic fraction (lanes 2 and 5). This suggests that c-ABL is auto-
phosphorylated in the chromatin fraction, and is consistent with the fact that c-ABL-wt but
not c-ABL-kd in the chromatin fraction is tyrosine-phosphorylated (unpublished data).
Secondly, we found extensive chromatin association of not only transfected RAD51-wt but
also endogenous RAD51 (second row, lane 7). Since the chromatin association of endogenous
RAD51 was not detectable in the absence of transfected RAD51 (unpublished data), the
extensive chromatin association of transfected RAD51-wt as well as endogenous RAD51
appeared to be stimulated by transfection procedures. However, when cells were transfected
with RAD51-R167G, the chromatin association of not only transfected RAD51-R167G but
also endogenous RAD51 was minimal (second row, lane10). This is consistent with the
finding that RAD51-R167 failed to associate with endogenous RAD51 (Supplementary Fig.
2A), and further suggest that the observed defect of RAD51-R167G in chromatin association
is primarily due to its inability to self-associate. Finally, we found that co-transfection of c-
ABL-wt but not c-ABL-kd with RAD51-R167G greatly enhanced the chromatin association
of not only RAD51-R167G but also endogenous RAD51 (second row, lanes 10-12); slight
enhancement of the chromatin association of transfected RAD51-wt and endogenous RAD51
by c-ABL-wt but not by c-ABL-kd expression was also observed (second row, lanes 7-9). We
also found that imatinib effectively inhibited c-ABL-mediated enhancement of RAD51-
R167G chromatin association (Supplementary Fig. 3).
To study whether c-ABL actually phosphorylates Tyr-54 or Tyr-315 on RAD51 under the
conditions studied, HA-tagged wild-type RAD51 or various mutants, RAD51-R167G,
RAD51-Y54F or RAD51-Y315F (Tyr-54 and Tyr-315 were substituted with Phe in Y54F and
Y315F, respectively) were transiently co-expressed with Flag-tagged c-ABL-wt in 293T cells,
and the cytoplasmic and chromatin fractions were subjected to immunoblot analysis using
antibodies specific for phosphorylated Tyr-54 or Tyr-315. As shown in Fig. 1B, c-ABL
phosphorylated both of Tyr-54 and Tyr-315 on RAD51-WT (third and fourth rows, lane 10)
and RAD51-R167G (third and fourth rows, lane 16), but not Tyr-54 on RAD51-Y54F (third
row, lane 12), or Tyr-315 on RAD51-Y315F (fourth row, lane 14). Interestingly, we detected
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consistent with the findings that c-ABL auto-phosphorylation, which is required for c-ABL
activation [22, 23], is detected only in the chromatin fraction, as described above. To test the
generality of this finding that c-ABL restore the defective chromatin association of self-
association-defective RAD51-R167G, GFP-tagged RAD51-WT or RAD51-F86E were
transiently co-expressed with Flag-tagged c-ABL-wt or c-ABL-kd in 293T cells and the
cytoplasmic and chromatin fractions were subjected to immunoblot analysis. As shown in Fig.
1C, when cells were transfected with GFP-RAD51-F86E, the chromatin association of not
only transfected GFP-RAD51-F86E but also endogenous RAD51 was minimal (second and
third rows, lane 10), and cotransfection of c-ABL-wt but not of c-ABL-kd enhanced the
chromatin association of not only transfected GF-RAD51-F86E but also endogenous RAD51
(second and third rows, lanes10-12). We also observed the phosphorylation of GFP-RAD51-
WT and GFP-RAD51-F86E on Tyr-54 only in the chromatin fraction (fourth row, lanes 8 and
11), though the phosphorylation of Tyr-315 was detected both the cytoplasmic and chromatin
fractions (fifth row, lanes 2, 5, 8 and 11). The reason for this difference is not clear at present
time. It is possible that the large GFP-tag but not the HA-tag influences the in vivo
phosphorylation by c-ABL.
The self-association defective GFP-RAD51-F86E mutant was previously shown to be
defective in IR-induced nuclear focus formation [15]. In agreement with this finding, and
consistent with the results shown in the Fig 1 that GFP-RAD51-F86E cannot stably associate
with the chromatin, GFP-RAD51-F86E did not form typical RAD51 nuclear foci following
IR stimulation, and a significant chromatin staining was not observed (Fig 2A, right panel).
The RAD51-R167G mutant also showed defective IR-induced nuclear focus formation and
could not stably associates with chromatin (Fig 2A, left panel), as expected. Since c-ABL can
restore the chromatin association of these self-association-defective RAD51 mutants as shown
in Fig 1, we were interested to examine whether c-ABL can restore the defect of these RAD51
mutant in IR-induced nuclear focus formation. We therefore transiently co-expressed these
RAD51 mutants with c-ABL in 293T cells, with or without IR stimulation. As shown in Fig.
2B, c-ABL co-expression restored the chromatin association of these mutants, but not typical
IR-induced nuclear focus formation. Thus, c-ABL can restore the stable chromatin association
of self-association-defective RAD51 mutants, but cannot restore the defective IR-induced
9nuclear focus formation, which depends on the ability of RAD51 to self-associate. Since c-
ABL can phosphorylate both of Tyr-54 and Tyr-315 on these self-association-defective
RAD51 mutants in the chromatin fraction (Fig. 1), it was of interest to study which tyrosine
residue is involved in the restoration of the stable chromatin association of self-association-
defective RAD51 mutants. We therefore substituted Tyr-54 or Tyr-315 with Phe in RAD51-
R167G to create RAD51-R167G/Y54F or RAD51-R167G/Y315F. These HA-tagged RAD51
mutants (RAD51-R167G, RAD51-R167G/Y54F and RAD51-R167G/Y315F) were then
transiently co-expressed with Flag-c-ABL in 293T cells. As shown in Fig. 2C, while the
mutation of Tyr-54 did not influenced the ability of c-ABL to restore the chromatin-
association defect of RAD51-R167G, the mutation of Tyr-315 abrogated the ability of c-ABL
to restore the chromatin-association defect of this mutant, indicating that the phosphorylation
of Tyr-315 plays a critical role in the restoration of the stable chromatin association of self-
association-defective RAD51 mutants.
It is now well established that BRCA2 plays an essential role in the chromatin assembly of
RAD51 during HRR [3]. Since we have not been so far able to detect a stable interaction
between BRCA2 and c-ABL in vivo and c-ABL can bind to the chromatin in BRCA2-
deficient Capan cells (unpublished data), it seems likely that c-ABL is recruited to chromatin
independently of BRCA2, where it phosphorylates RAD51 transported to sites of DNA
damage by BRCA2. This phosphorylation, mainly on Tyr-315, enhances/stabilizes the
chromatin association of RAD51 proteins, assisting their assembly into an active
nucleoprotein intermediate, a step which is again dependent on BRCA2 [3]. This hypothesis is
consistent with the location of Tyr-315 in the possible 3-D RAD51 filament structure, which
is located at the edge of the subunit-subunit interface and exposed on the inner surface of
filament structure (see Supplementary Fig. 1). c-ABL cannot restore the ability of the self-
association defective mutants to form IR-induced nuclear foci. Therefore, c-ABL may
conceivably function at an early step in the recruitment of RAD51 to chromatin, which
precedes nucleoprotein filament formation via RAD51-RAD51 self-association. We have not
so far been successful in detecting in vivo Tyr-54/Tyr-315 phosphorylation of endogenous
RAD51 following IR stimulation (unpublished data), raising the possibility that RAD51
modification by c-ABL may only be transient. Overall, this hypothetical proposal for c-ABL-
mediated regulation of RAD51 in vivo is consistent with the results of our previous in vitro
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study showing that the replacement of Tyr-315 with acidic Asp or Glu residues, mimicking
constitutive Tyr-315 phosphorylation, impairs dsDNA binding [18].
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Figure Legends
Figure 1. c-ABL restores the chromatin association of self-association-defective RAD51
mutants.  (A) Flag-tagged wild-type (wt: lanes 2, 5, 8, 11) or kinase-dead (kd: lanes 3, 6, 9,
12) c-ABL and HA-tagged wild-type (WT: lanes 1-3 and 7-9) or R167G mutant (lanes 4-6
and 10-12) RAD51 expression vectors were transiently co-transfected into 293T cells in
various combinations as indicated: in lanes 1, 4, 7 and 10, empty vectors (ev) were transfected.
Forty-eight hour after transfection, cells were fractionated into the cytoplasmic (lanes 1-6) and
chromatin-associated (lanes 7-12) fractions, and these fractions were subjected to immunoblot
analysis with anti-Flag (c-ABL, first row), anti-human RAD51 (HA-RAD51 and endo-
RAD51, second row), anti-a-Tubulin, anti-Histone-H3 and anti-b-Actin antibodies; HA-
RAD51 and endo-RAD51 denotes transfected HA-tagged RAD51 and endogeneous RAD51,
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respectively. (B) Flag-tagged wild-type c-ABL (wt: lanes 2, 4, 6, 8, 10, 12, 14, 16) and HA-
tagged wild-type (WT: lanes 1-2 and 9-10) or various mutants (Y54F, lanes 3-4 and 11-12;
Y315F, lanes 5-6 and 13-14; R167G, lanes 7-8 and 15-16) RAD51 expression vectors were
transiently co-transfected into 293T cells in various combinations as indicated: empty vectors
(ev) were transfected in lanes 1, 3, 5, 7, 9, 11, 13, 15. Forty-eight hour after transfection, cells
were fractionated into the cytoplasmic (lanes 1-8) and chromatin-associated (lane 9-16)
fractions. These fractions were subjected to immunoblot analysis with anti-Flag (c-ABL, first
row), anti-human RAD51 (HA-RAD51 and endo-RAD51, second row), anti-phospho-Y54
(third row), or anti-phospho-Y315 (fourth row) antibodies. (C) Flag-tagged empty (ev: lanes 1,
4, 7 and 10), wild-type (wt: lanes 2, 5, 8 and 11) or kinase-dead (kd: lanes 3, 6, 9 and 12) c-
ABL and GFP-tagged wild-type (WT: lanes 1-3 and 7-9) or mutant (F86E: lanes 4-6 and 10-
12) RAD51 expression vectors were transiently co-transfected into 293T cells in various
combinations as indicated. Forty-eight hour after transfection, cells were fractionated into the
cytoplasmic (lanes 1-6) and chromatin-associated (lane 7-12) fractions, and these fractions
were subjected to immunoblot analysis with anti-Flag (c-ABL, first row), anti-GFP (GFP-
RAD51, second row), anti-RAD51 (endo-RAD51, third row), anti-phospho-Y54 (fourth row)
or anti-phospho-Y315 (fifth row) antibodies.
Figure 2. The restoration of defective chromatin association of RAD51-R167G by c-ABL
is dependent on Tyr-315.  
(A) Forty-eight hour after transfection with the HA-tagged or GFP-tagged wild-type (WT), or
mutant (HA-R167G or GFP-F86E) RAD51 expression vectors into 293T cells, cells were
exposed to IR (10 Gy) or untreated (Control). Three hour after IR treatment, RAD51 foci
were visualized with anti-RAD51 antibodies. (B) HA-tagged RAD51-R167G or GFP-tagged
RAD51-F86E and Flag-tagged empty (vector) or c-ABL expression vectors were transiently
co-transfected into 293T cells as indicated. (C) HA-tagged RAD51 mutant (R167G,
R167G/Y54F and R167G/Y315F) and Flag-tagged empty (vector) or c-ABL expression
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